QuiVad
My list

Home / Funds / Guevoura Fund

Guevoura Fund

Every short position this fund has disclosed, market by market.

Follow

This fund discloses no open short position today.

Follow by RSS

Get the moves on Guevoura Fund by mail.

No account: one address, one link to confirm, one link to stop in every message.

History of disclosures

329 disclosures on record for this fund.
DateIssuerMarket% of capitalEnd of publication
September 8, 2026Cell Impact AB (publ)Sweden1.00%
September 3, 2026Cell Impact AB (publ)Sweden0.96%
September 1, 2026Cell Impact AB (publ)Sweden0.85%
August 31, 2026Cell Impact AB (publ)Sweden1.88%
August 28, 2026Cell Impact AB (publ)Sweden1.67%
August 27, 2026Cell Impact AB (publ)Sweden0.76%
August 20, 2026Precise Biometrics ABSweden0.56%
August 18, 2026Precise Biometrics ABSweden0.79%
August 17, 2026Precise Biometrics ABSweden0.69%
August 14, 2026Precise Biometrics ABSweden0.89%
August 10, 2026Precise Biometrics ABSweden0.75%
August 6, 2026Precise Biometrics ABSweden0.65%
June 29, 2026Intrum ABSweden1.09%
June 26, 2026Aktiebolaget ElectroluxSweden0.61%
June 25, 2026Aktiebolaget ElectroluxSweden1.67%
June 24, 2026Intrum ABSweden0.95%
June 23, 2026Aktiebolaget ElectroluxSweden1.56%
June 23, 2026Intrum ABSweden0.88%
June 22, 2026Aktiebolaget ElectroluxSweden1.45%
June 22, 2026Intrum ABSweden0.71%
June 22, 2026Dicot Pharma ABSweden0.66%
June 18, 2026Intrum ABSweden0.67%
June 17, 2026Aktiebolaget ElectroluxSweden1.31%
June 17, 2026Dicot Pharma ABSweden1.10%
June 17, 2026Intrum ABSweden0.56%
June 16, 2026Dicot Pharma ABSweden1.02%
June 12, 2026Precise Biometrics ABSweden1.01%
June 12, 2026Dicot Pharma ABSweden0.92%
June 11, 2026Aktiebolaget ElectroluxSweden1.23%
June 11, 2026Dicot Pharma ABSweden0.87%
June 10, 2026Precise Biometrics ABSweden0.96%
June 10, 2026Aktiebolaget ElectroluxSweden0.90%
June 9, 2026Aktiebolaget ElectroluxSweden0.75%
June 9, 2026Dicot Pharma ABSweden0.66%
June 8, 2026Precise Biometrics ABSweden0.81%
June 4, 2026Precise Biometrics ABSweden0.79%
June 4, 2026Dicot Pharma ABSweden0.51%
March 24, 2026Oncopeptides ABSweden1.37%
March 20, 2026Oncopeptides ABSweden1.50%
March 19, 2026Oncopeptides ABSweden1.49%
March 18, 2026Oncopeptides ABSweden1.87%
March 17, 2026Oncopeptides ABSweden1.33%
March 16, 2026Oncopeptides ABSweden0.81%
March 16, 2026Nobia ABSweden0.50%
March 12, 2026Oncopeptides ABSweden0.54%
March 10, 2026Cell Impact AB (publ)Sweden1.23%
March 9, 2026Cell Impact AB (publ)Sweden1.10%
March 6, 2026Cell Impact AB (publ)Sweden0.99%
March 5, 2026Cell Impact AB (publ)Sweden1.43%
March 4, 2026Cell Impact AB (publ)Sweden1.30%

Download 329 filings as CSV Columns: Date, Issuer, Market, Disclosed position, Unit, End date. The other formats

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Guevoura Fund, data as at September 8, 2026, https://www.quivad.com/detenteur/guevoura-fund